|
Protocol Number:
98-EI-0076
- Title:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Retinovascular Diseases
- Number:
98-EI-0076
- Summary:
This screening protocol is designed to help recruit patients for National Eye Institute (NEI) studies of the retina, such as diabetic retinopathy and macular degeneration. Patients must meet the specific criteria of a research study, and this protocol serves as a first step for admitting patients to a retinal disease study.
Candidates will undergo a medical history and comprehensive eye examination. The eye examination includes dilation of the pupils to fully examine the retina. In some studies, photographs of the eye are required. This is done using fluorescein angiography. In this procedure, a dye called sodium fluorescein is injected into the blood stream through a vein. After the dye reaches the blood vessels of the eye, photographs are taken of the retina. Other diagnostic procedures may include physical examination, questionnaires, routine laboratory tests and other standard or specialized tests, as needed.
When the screening is completed, patients will be informed of their options to participate in a study. Patients who are ineligible for a current study will be informed of alternative treatments or options. No treatment is offered under this protocol.
- Sponsoring Institute:
-
National Eye Institute (NEI)
- Recruitment Detail
- Type:
Active Accrual Of New Subjects
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION/EXCLUSION CRITERIA
Inclusion and exclusion criteria vary with the particular protocol for which a patient is being screened.
In addition to those diagnoses currently under study, subjects with unknown conditions that require the establishment of a diagnosis may be eligible for inclusion in this study.
All studies of retinovascular diseases require the subject to have minimum age of 18 years in both men and women.
- Special Instructions:
Currently Not Provided
- Keywords:
-
Diabetic Retinopathy
-
Age-Related Macular Degeneration
-
Neovascularization
- Recruitment Keywords:
-
Macular Degeneration
-
Retinal Disease
-
Diabetic Retinopathy
-
Diabetes
- Conditions:
-
Diabetic Retinopathy
-
Macular Degeneration
-
Pathologic Neovascularization
-
Retinal Disease
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Contacts:
-
Patient Recruitment and Public Liaison Office
Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 Electronic Mail:prpl@mail.cc.nih.gov
- Citations:
Not Provided
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
Warren Grant Magnuson Clinical Center (CC) National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/27/2004
|
|